Program at a Glance
Day 1 - March 27 (Thursday)
| Date/Time | Room 1 | Room 2 | Room 3 | Room 4 |
|---|---|---|---|---|
| Vista 1 (B2F) | Vista 2 (B2F) | Grand 1 (B1F) | Art Hall (4F) | |
| 08:50-09:00 | Opening Remark | |||
| 09:00-10:15 | Joint Session 01 (MOU Session) Adult Acute Lymphoblastic Leukemia in Asia | Scientific Session 01 Improving outcomes in challenging Pediatric Leukemia | Scientific Session 02 Overcoming the resistance mechanisms of Multiple Myeloma | Education Session 01 Understanding the fundamentals of Myelodysplastic Syndrome KOR |
| 10:15-10:30 | Break | |||
| 10:30-11:15 | Plenary Lecture 01 Myeloproliferative Neoplasms: 2025 update | |||
| 11:15-12:00 | Presidential Symposium 01 CAR T-cell therapy for Lymphomas: Current and future trends | |||
| 12:00-12:15 | Break | |||
| 12:15-13:05 | Satellite Symposium 01 | Satellite Symposium 02 | Satellite Symposium 03 | Satellite Symposium 04 |
| 13:05-13:45 | Poster Viewing 1 (Walker Hall, 1F) | |||
| 13:45-13:55 | Break | |||
| 13:55-15:10 | Oral Presentation 01 | Oral Presentation 02 | Oral Presentation 03 | Oral Presentation 04 |
| 15:10-15:25 | Break | |||
| 15:25-16:40 | Joint Sesseion 02 (EHA-KSH) Acute Myeloid Leukemia - Research and practice | Scientific Session 03 Updates in cancer-associated Venous Thromboembolism | Scientific Session 04 Advancements in Peripheral T-cell Lymphoma: From biological insights to innovative treatments | Education Session 02 Basic understanding and application of Artificial Intelligence KOR |
| 16:40-16:55 | Break | |||
| 16:55-18:10 | Scientific Session 05 Red blood cells in Myeloproliferative Neoplasm | Scientific Session 06 Advances and challenges in Histiocytic diseases: A comprehensive update | Scientific Session 07 Breaking new ground in Acute Myeloid Leukemia | Education Session 03 Turning ideas into successful Clinical Trial: A practical approach KOR |
| 18:45~ | Welcome Reception (Aston House) | |||
Day 2 - March 28 (Friday)
| Time | Room 1 Vista 1 (B2F) |
Room 2 Vista 2 (B2F) |
Room 3 Grand 1 (B1F) |
Room 4 Art Hall (4F) |
Room 5 Grand 4+5 (B1F) |
|---|---|---|---|---|---|
| 09:00-10:15 | Joint Session 03 (ASH-KSH) Chronic Myeloid Leukemia - Era of Next-Generation Sequencing | Scientific Session 08 TP53 alterations in hematological malignancy: From clonal hematopoiesis to acute leukemia | Scientific Session 09 Advancing the paradigm in Adult Acute Lymphoblastic Leukemia care | Education Session 04 Minimal residual disease: Tailored treatment strategies for hematologic malignancies | |
| 10:15-10:30 | Break | ||||
| 10:30-11:15 | Plenary Lecture 02 Targeting CD38 in Plasma cell disorder: From basics to clinics and beyond | ||||
| 11:15-12:00 | Poster Viewing 2 (Walker Hall, 1F) | ||||
| 12:00-12:15 | Break | ||||
| 12:15-13:05 | Satellite Symposium 05 | Satellite Symposium 06 | Satellite Symposium 07 | Satellite Symposium 08 | Satellite Symposium 09 |
| 13:05-13:35 | Break | ||||
| 13:35-14:50 | Oral Presentation 05 | Oral Presentation 06 | Oral Presentation 07 | Oral Presentation 08 | |
| 14:50-15:05 | Break | ||||
| 15:05-16:20 | Education Session 05 Up-to-date management of Multiple Myeloma | Scientific Session 10 Next steps toward enhanced treatment for Pediatric Lymphoid malignancies | Scientific Session 11 Driving the future of our CAR | Education Session 06 Patient care in Cytopenia consultations: Best practices for hematologists KOR | |
| 16:20-16:35 | Break | ||||
| 16:35-17:50 | Joint Session 04 (Asia Session) Dawn of CAR-T therapy: Asian perspective | Scientific Session 12 Cutting-edge Diagnostic Techniques in hematology | Scientific Session 13 Innovations in aplastic anemia and Paroxysmal Nocturnal Hemoglobinuria | Education Session 07 Treatment of indolent & Hodgkin Lymphoma | |
| 18:30~ | Gala Dinner (Théâtre des Lumières) | ||||
Day 3 - March 29 (Saturday)
| Time | Room 1 Vista 1 (B2F) |
Room 2 Vista 2 (B2F) |
Room 3 Grand 1 (B1F) |
Room 4 Art Hall (4F) |
|---|---|---|---|---|
| 07:30-08:00 | KSH Business Meeting | |||
| 08:00-09:00 | Young Investigator Award Presentation | |||
| 09:00-10:15 | Joint Session 05 (Asia Session) MRD and Immunotherapy in Multiple Myeloma: Collaborative insights from Korea and Japan | Scientific Session 14 Deciphering blood Coagulation Tests | Scientific Session 15 Immunotherapy in B-Cell Lymphoma: Current status and emerging approaches | Education Session 08 Supportive care: Management of infections and iron overload KOR |
| 10:15-10:30 | Break | |||
| 10:30-11:15 | Plenary Lecture 03 New discoveries that will shape future therapies in Chronic Myeloid Leukemia | |||
| 11:15-11:30 | Break | |||
| 11:30-12:00 | Closing Ceremony | |||
| 12:00-12:30 | KSH General Assembly | |||
- Hosted by
-
- Supported by
-
Sponsored by
- Zeus
-
- Hercules
-
